Another episode in the expert opinion series. I thought this might be useful for some of you after an interesting ‘google alert’ brought up these discussions. It comprises a roundtable discussion with known NET specialists and some big hitters too. Dr Jonathan Strosberg is another favourite of mine, not only because he is a prodigious researcher, writing and helping to write various studies on NETs. Plus, I’ve actually met him!
Jonathan R. Strosberg, MD
Professor of Gastrointestinal Oncology
Section Head, Neuroendocrine Tumor Division
Chair, Gastrointestinal Department Research Program
Moffitt Cancer Center
Tampa, FL
The discussion is centred on the following statement and question
Small-bowel neuroendocrine tumors (NETs) will eventually progress* during ongoing somatostatin analogue (SSA) therapy. Treatment options for progressive disease are limited, but emerging therapies may offer new hope for these challenging-to-treat patients. (* remember the title contains the term “advanced”).
Systemic Treatments for Advanced, Well-Differentiated, Small-Bowel Neuroendocrine Tumors That Progress on Somatostatin Analogues – Expert Perspectives
Click on the blue link below to read the discussion.
Expert Perspectives | Systemic Treatments for Advanced, Well-Differentiated, Small-Bowel Neuroendocrine Tumors That Progress on Somatostatin Analogues – Expert Perspectives
Disclaimer
I am not a doctor or any form of medical professional, practitioner or counsellor. None of the information on my website, or linked to my website(s), or conveyed by me on any social media or presentation, should be interpreted as medical advice given or advised by me.
Neither should any post or comment made by a follower or member of my private group be assumed to be medical advice, even if that person is a healthcare professional.
Please also note that mention of a clinical service, trial/study or therapy does not constitute an endorsement of that service, trial/study or therapy by Ronny Allan, the information is provided for education and awareness purposes and/or related to Ronny Allan’s own patient experience. This element of the disclaimer includes any complementary medicine, non-prescription over the counter drugs and supplements such as vitamins and minerals.
Click here and answer all questions to join my private Facebook group
Thanks for reading.
Ronny
Check out my WEGO Health Awards
Check out my Glossary of Terms – click here
Please Share this post for Neuroendocrine Cancer awareness and to help another patient
The Classification, Grading and Staging of Neuroendocrine Neoplasms (incorporating WHO 2026 classification changes)March 11, 2024Patient AdvocacyDiscover more from Ronny Allan - Living with Neuroendocrine Cancer
Subscribe to get the latest posts sent to your email.












Very helpful. Thank you, Ronny!